Overview and registration fees

This event is now closed for bookings. Please contact meetings@rcpath.org for any further information.

Overview

There are exciting ongoing developments in transfusion medicine and science with high quality research supporting evidence-based practice. This one-day virtual meeting organised on behalf of the Royal College of Pathologists brings together experts from various clinical disciplines with leaders in transfusion science to provide an update on key developments. The meeting will be of interest to all those involved in transfusion medicine.  

Registration Fees

RCPath Fellows: £70
Concessions: £50 (Trainees, BMS, Nurses, Retired)
Non-members: £90

IMPORTANT: Invoices will not be processed within a month of the event. Please discuss alternative arrangements with the team at meetings@rcpath.org 

Programme

Thursday 26 November 2020 

  • 09:55     Introduction & housekeeping - Dr Shubha Allard 
  • 10:00     Welcome - President, Royal College of Pathologists

Foundation Lecture Chaired by RCPath President

  • 10:05 Human Blood Groups – Past, Present & Future - Professor Martin Olsson

Evidence based transfusion practice: Chairs – Dr Shubha Allard & Professor Beverley Hunt

  • 10:25 Traumatic Haemorrhage including role of whole blood – Dr Laura Green
  • 10:45 Major Obstetric Haemorrhage – developments and future challenges – Professor Peter Collins
  • 11:05 Sickle Cell Disease and potential impact of new therapies – Dr Banu Kaya 
  • 11:25 Open discussion
  • 11:35 Break

Advances in transfusion science: Chaired by Professor Cheng–Hock Toh

  • 11:50 Update on 100 000 genome project – Professor Willem Ouwehand  
  • 12:10 Use of CAR T cells – an overview – Dr James Griffin  
  • 12:30 COVID-19 convalescent plasma – what’s the evidence? – Dr Lise Estcourt 
  • 12:50 Open discussion
  • 13:00 Lunch

British Blood Transfusion Society (BBTS) section: Chairs – Dr Heidi Doughty & Jenny White 

  • 13:30 Young investigator talk 1 - Effects of the first wave of CoViD-19 on wrong blood in tube events: implications for future preparedness - Strachan Mackenzie (based on best abstract submission)
  • 13:45 Young investigator talk 2 - Cold Stored Platelets Correct Cardiac Surgery Induced Platelet Dysfunction - Tom Scorer (based on best abstract submission)
  • 14:00 Evidence based patient blood management (PBM) – Professor Simon Stanworth 
  • 14:20 Percy Oliver Award
  • 14:30 Break

Transfusion Safety & clinical transfusion: Chaired by Dr Sharran Grey

  • 14:45 Patient blood management - the good, the bad and the ugly – Wendy McSporran
  • 15:05 SHOT – achievements and challenges - Dr Shruthi Narayan
  • 15:25 Autoimmune haemolytic anaemia and advances – Dr Quentin Hill  
  • 15:45 Open discussion
  • 16:00 Close  
Abstracts/Posters

The Royal College of Pathologists invites doctors-in-training, transfusion practitioners, and transfusion scientists to submit abstracts for presentation at the Advances in Transfusion Medicine Symposium. Abstracts can be on any aspect of transfusion medicine and should present new data from studies, audits, quality improvement projects or systematic reviews. The abstract submission deadline has been extended to by midnight on Sunday 4 October 2020. Abstracts should be submitted via email at meetings@rcpath.org. All submissions must include a clear and concise abstract of no more than 300 words in English that satisfies all of the abstract guidelines.

Presentations 

There will be 2 oral virtual presentations at the symposium. We will select: 

  • the highest scoring abstract on audits or quality improvement projects 
  • the highest scoring abstract on clinical or laboratory studies or systematic reviews 

Each author will receive free meeting registration for Thursday 26 November and the abstract will be published in Transfusion Medicine.

Posters

Winning entry

Entries

 

Zoom

ZOOM

This meeting will be held via Zoom. Details of the meeting with accompanied guidance will be sent to attendees before the meeting. We strongly suggest you download Zoom to your computer/laptop to make the most of the meeting, however if this is not possible just simply click on the link provided. To Find out more about Zoom and how it works please visit the website

Please note: If you experience any problems when connecting to your Zoom meeting, such as lagging or freezing, then this may indicate that there is an issue with your internet connection, or the device you are using. We suggest that you try to move to an area with a more stable connection and then re-join the meeting. We unfortunately will not be able to provide you with a refund or transfer you onto another event if you happen to encounter these problems on the day. 

Speakers

ADVANCES IN TRANSFUSION MEDICINE

  • Dr Shubha Allard

    Shubha Allard MD FRCP FRCPath, Consultant Haematologist, NHS Blood and Transplant. Clinical Director for NHSBT Patient Blood Management Consultants Team and Secretary National Blood Transfusion Committee.  Actively promoting Patient Blood Management together with key activities needed to support safe clinical and laboratory transfusion practice including guidelines and implementation, clinical audit, education and training together with steering national policies. As current RCPath Clinical Director for Publishing & Engagement actively promoting the role and expertise of various pathology specialities in patient care together with wider public awareness.

  • Professor Peter Collins

    Peter Collins is a professor in haematology at the School of Medicine of Cardiff University and an honorary consultant haematologist at the Cardiff Haemophilia Centre. He is vice chair of the UK Haemophilia Centre Doctors’ Organisation and chairs the Data Management Working Party of the UK National Haemophillia Database. 

    His clinical research interests include acquired haemophilia, prophylactic treatment of haemophilia, factor VIII inhibitors, pharmacokinetics of factor VIII and IX, haemostatic impairment during postpartum haemorrhage. Basic science interests are the role of phospholipids in controlling coagulation and interactions between coagulation and complement. 

  • Dr Lise Estcourt

    Lise Estcourt is a Consultant Haematologist for NHS Blood and Transplant, and Senior Clinical Lecturer in Transfusion Medicine. Her research in transfusion medicine focuses on the safe and appropriate use of blood components and their alternatives. Her research work involves systematic reviews (Cochrane and non-Cochrane); clinical trials; and clinical studies. She works with several other organisations to improve health and healthcare. She is the Clinical Lead for the National Comparative Audit in Blood Transfusion, Director of NHSBT Clinical Trials Unit and Clinical Tutor for NHSBT. She is the co-ordinating editor of Cochrane Haematological Malignancies and an editor of the journal Transfusion Medicine.”

  • Dr Sharran Grey

    Dr Sharran Grey is a Consultant Clinical Scientist in the Clinical Haematology Department at the Lancashire Haematology Centre: a tertiary haematology service serving Lancashire and South Cumbria. In addition to her clinical work, her responsibilities are consultant lead for haematology and transfusion laboratories across Blackpool and Preston, and consultant lead for Clinical Blood Transfusion. She is also the working expert for Transfusion-Associated Circulatory Overload with SHOT, and contributes to the writing of guidelines and papers at a national and international level.

  • Professor Beverley Hunt

    Professor of Thrombosis & Haemostasis at King’s College London; 
    Consultant in the Departments of Haematology & Pathology at Guy’s & St Thomas NHS Foundation Trust; & Clinical Lead in Haematological Sciences at Viapath LLP

    Clinical & laboratory
    She has a large clinical practice, specialising in thrombosis and haemostasis & obstetric haematology. She leads on the management of thrombosis within GSTT. She set up the GSTT award-winning “Thrombosis” app – thrombosis management in elegant algorithms
    Her laboratory work includes sitting on the board of Viapath LLP and leading in all aspects of haematological laboratory work. 

    Research & Development
    She runs a research group with over 360 peer-reviewed publications to her name, and won the BMJ Research paper of the year 2011 with the CRASH-2 team.  
    She led on behalf of the UK thrombosis and haemostasis community in a successful bid to bring the ISTH meeting (10-12,000 delegates) to the Excel Centre, London in 2022 
    She was awarded an OBE in the Queen’s birthday honours list in 2019 for services to medicine
    In the COVID-19 pandemic she has become an international expert on thrombosis and coagulopathy in COVID-19 patients, and has given numerous webinars including being an expert witness for the British House of Lords Science and Technology Committee. She has also given numerous media interviews including working with BBC News.
     

  • Dr Banu Kaya

    Dr Banu Kaya is a consultant haematologist at Barts Health NHS Trust, London and honorary Clinical Senior Lecturer, Barts and The London School of Medicine and Dentistry, Queen Mary University of London. 

    Dr Kaya led the paediatric component of the National Haemoglobinopathy Peer Review Programme and co-chaired the steering group, 2014-2016. She was appointed to the haemoglobinopathies Clinical Reference Group in 2019 and jointly leads the regional Haemoglobinopathy Coordinating Centre. She is a Trustee of the British Society of Haematology. 

    Dr Kaya has been the UK Chief Investigator for a number of international clinical trials and has contributed to a number of recent national guidelines. 
     

  • Strachan Mackenzie

    I am a Haematology ST6 Registrar and have undertaken my Haematology training in the north central London deanery, with the majority of my training spent at University College Hospital. I am currently undertaking a split-site PhD through UCL and the University of Pennsylvania in Philadelphia. My PhD project is exploring the mechanisms of resistance in CAR-T therapy for acute myeloid leukaemia and is trying to determine why CAR-T outcomes in this group remain poor.  Skills I’ve developed during Covid include patience, resilience and cooking vegetable curry.

  • Professor Martin L. Olsson

    Martin L. Olsson received his M.D. in 1991 and Ph.D. in 1997 from Lund University in Sweden where he is currently a full Professor and Senior Consultant in Transfusion Medicine. He was a guest researcher at the International Blood Group Reference Laboratory in Bristol in 1996 and a Visiting Associate Professor at Harvard Medical School in 2003-2008. Olsson is currently Vice Dean of the Faculty of Medicine in Lund, as well as Medical Director of the Nordic Reference Laboratory there. His main clinical and research interest is the molecular genetics of blood groups and their functional roles in health and disease. His many awards include prestigious prizes from BBTS, ISBT, AABB and others. He served as the President of ISBT in 2018-2020.

  • Professor Willem H Ouwehand

    Willem H Ouwehand is University of Cambridge Professor of Experimental Haematology, holds honorary appointments at Cambridge University Hospitals, NHS Blood and Transplant and the Welcome Sanger Institute and is a Fellow of the Academy of Medical Sciences. His recent research has been on rare diseases with a focus on inherited bleeding, platelet and thrombotic disorders. As a founder of the NIHR BioResource, Willem has coordinated the NIHR BioResource whole-genome sequencing study for Rare Diseases for the 100,000 Genomes Project.

    In his long-standing collaboration with Professor Nicole Soranzo, he has worked with her on unravelling the genetic architecture of blood cell formation by performing genome-wide association studies for full blood cell count parameters in large-scale population studies, including the Donor Health Cohorts INTERVAL, COMPARE and now STRIDES.

    In 2016 he founded with Dr Nick Gleadall the Blood transfusion Genomics Consortium, a collaborative on blood cell immunogenetics in 7 countries and across 4 continents. The Consortium brings together experts in immunogenetics, computer science and bioinformatics, statistical genomics, genotyping instrumentation & array design and regulatory matters from Blood Services, Academia and Industry. The aim of the consortium is to bring an affordable DNA test for high throughput blood cell antigen typing of donors and patients to the frontline of transfusion to support better matching in frequently transfused patients. 

    He lives in Cambridge, is married to Sally with whom he has two daughters.

  • Professor Simon J. Stanworth

    Professor Simon J. Stanworth is Consultant Haematologist for NHS Blood & Transplant at the John Radcliffe Hospital,  Oxford University Hospitals NHS Foundation Trust, and the University of Oxford. His research as a Principal Investigator in Clinical Research in transfusion medicine is centered on clinical indications of blood components and use of alternatives. He is Chair of the Specialty Working Group for Transfusion for the European Haematology Association, and deputy Chair for the International Committee Transfusion Medicine Guidelines (ICTMG). He is Secretary of the Regional Transfusion Committee for Oxford and Southampton/Hants.

  • Professor Cheng-Hock Toh

    Cheng-Hock Toh is Professor of Haematology at Liverpool and Chair of the National Blood Transfusion Committee. He is Academic Vice-President of the Royal College of Physicians London and immediate Past President of the British Society for Haematology.

  • Jenny White

    Jenny has recently taken on the role of Executive Director at the International Society of Blood Transfusion (ISBT). She has a background in biomedical science and worked both in the NBS and as a hospital transfusion laboratory manager before specialising  EQA at UK NEQAS for more than 20 years. Jenny has been involved in developing BSH transfusion guidelines,  chaired the BBTS Professional Affairs and Education Committee and acted as a RCPath examiner for the FRCPath examination in Transfusion Science.

  • Dr Heidi Doughty

    Heidi Doughty is a consultant in Transfusion Medicine working for NHS Blood and Transplant based in Birmingham, UK.  She qualified in medicine from Cambridge University in 1985 before undertaking higher training in internal medicine, haematology and management in Nottingham and London. She completed her doctoral thesis in military transfusion medicine in Bergen, Norway. 

    She chairs the National Blood Transfusion Committee Emergency Planning working group and is president of the British Blood Transfusion Society. She is an honorary Senior Research Fellow at the University of Birmingham and is affiliated with Birmingham’s NIHR Surgical Reconstruction and Microbiology Research Centre.  Her current interests include the development and delivery of pre-hospital transfusion and emergency planning. 
     

  • Dr Tom Scorer

    Tom is a final year haematology speciality trainee in the Severn Deanery, working at the Royal United Hospital, Bath. He graduated from Imperial College, London in 2006 and has served as a Medical Officer in the Royal Navy since 2003. He has served on submarines, surface ships and land including deployment to Oman and Afghanistan. He sits on the Defence Medical Services Transfusion Committee and the NATO Blood Panel as Secretary. He has recently completed his MD studies investigating the effectiveness of Cold Stored Platelets in Cardiac Surgery, a collaboration he formed between the US Army Institute of Surgical Research, San Antonio, Texas and University of Bristol.